Papers
2
Total Citations
37
H-Index
2
About
Anne Hong is a pioneering urologic surgeon and researcher whose work centers on advancing surgical techniques for complex genitourinary cancers, particularly testicular and prostate malignancies. Her major contributions lie in refining robot-assisted and open retroperitoneal lymph node dissections (RPLND) for testicular cancer patients, especially those who have undergone prior chemotherapy—a historically challenging cohort. Her landmark 2021 comparative study of 100 consecutive post-chemotherapy and primary RPLND cases (35 citations) established critical peri-operative outcome benchmarks, demonstrating that robotic approaches can reduce morbidity without compromising oncologic efficacy. More recently, Hong introduced a novel application of hyaluronic acid as a tissue spacer between the prostate and rectum during radical prostatectomy, a technique designed to facilitate dissection in patients with prior pelvic radiotherapy—a group at high risk for surgical complications. This innovative work, published in 2023, addresses a pressing clinical need by displacing the prostate away from the rectum, potentially lowering morbidity in salvage prostatectomy. With her focus on improving surgical precision and patient recovery, Hong’s research is shaping next-generation approaches to high-risk urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2